Chinese Manufacturer Cited for Failing to Disclose Information to FDA, Maintain GMP Standards in Warning Letter

Drug Industry Daily
The FDA handed Baoying County Fukang a warning letter after the company’s management withheld information from the agency and failed to maintain methods and controls in compliance with GMP standards.

To View This Article:


Subscribe To Drug Industry Daily